Mineralization of bones and teeth is tightly regulated by levels of extracellular inorganic phosphate (P i ) and pyrophosphate (PP i ). Three regulators that control pericellular concentrations of P i and PP i include tissue-nonspecific alkaline phosphatase (TNAP), progressive ankylosis protein (ANK), and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). Inactivation of these factors results in mineralization disorders affecting teeth and their supporting structures. This study for the first time analyzed the effect of decreased PP i on dental development in individuals with generalized arterial calcification of infancy (GACI) due to loss-of-function mutations in the ENPP1 gene. Four of the 5 subjects reported a history of infraocclusion, overretained primary teeth, ankylosis, and/or slow orthodontic tooth movement, suggesting altered mineral metabolism contributing to disrupted tooth movement and exfoliation. All subjects had radiographic evidence of unusually protruding cervical root morphology in primary and/or secondary dentitions. High-resolution micro-computed tomography (micro-CT) analyses of extracted primary teeth from 3 GACI subjects revealed 4-fold increased cervical cementum thickness (P = 0.00007) and a 23% increase in cementum density (P = 0.009) compared to age-matched healthy control teeth. There were no differences in enamel and dentin densities between GACI and control teeth. Histology revealed dramatically expanded cervical cementum in GACI teeth, including cementocyte-like cells and unusual patterns of cementum resorption and repair. Micro-CT analysis of Enpp1 mutant mouse molars revealed 4-fold increased acellular cementum thickness (P = 0.002) and 5-fold increased cementum volume (P = 0.002), with no changes in enamel or dentin. Immunohistochemistry identified elevated ENPP1 expression in cementoblasts of human and mouse control teeth. Collectively, these findings reveal a novel dental phenotype in GACI and identify ENPP1 genetic mutations associated with hypercementosis. The sensitivity of cementum to reduced PP i levels in both human and mouse teeth establishes this as a well-conserved and fundamental biological process directing cementogenesis across species (ClinicalTrials.gov NCT00369421).
Introduction
Bone and tooth mineralization is regulated by extracellular levels of inorganic phosphate (P i ) and pyrophosphate (PP i ). Regulators of pericellular P i and PP i concentrations include tissue-nonspecific alkaline phosphatase (ALPL gene; TNAP protein), which promotes mineralization by hydrolyzing PP i , an inhibitor of mineralization; progressive ankylosis protein (ANKH; ANK), which mediates intracellular to extracellular PP i transport; and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1; ENPP1), which converts adenosine triphosphate (ATP) into adenosine monophosphate (AMP) and PP i (Millán 2013) . Inactivating ENPP1 mutations are associated with generalized arterial calcification of infancy (GACI or GACI1; OMIM#208000), a rare autosomal recessive disorder characterized by prenatal-onset vascular calcification (Rutsch et al. 2003; Ferreira et al. 2014) . Bisphosphonates, synthetic nonhydrolyzable PP i analogues, are the current standard of care to prevent vascular calcifications and improve survival beyond infancy. Some GACI patients surviving past the first year of life develop fibroblast growth factor 23 (FGF23)-mediated hypophosphatemic rickets (ARHR2; OMIM#613312) (Levy-Litan et al. 2010; Lorenz-Depiereux et al. 2010 ).
Dentoalveolar mineralized tissues (i.e., enamel, dentin, cementum, and alveolar bone) are affected by metabolic disorders of mineralization (Opsahl Vital et al. 2012; Foster, Nociti, and Somerman 2014; Foster, Ramnitz, et al. 2014) . Cementum that covers the root surface and anchors the periodontal ligament is very sensitive to disturbances in the P i /PP i ratio. ALPL loss-of-function mutations cause increased PP i concentrations and hypophosphatasia (HPP; OMIM#241500/241510/146300), characterized by skeletal and dental hypomineralization, including inhibition of acellular cementum formation (Reibel et al. 2009; Foster, Ramnitz, et al. 2014) . Conversely, genetic ablation of Ank or Enpp1 in mice results in decreased PP i and increased cementogenesis (Nociti et al. 2002; . However, effects of low PP i levels on human dentoalveolar development have never been reported. This study for the first time reports the novel dental phenotype associated with biallelic inactivating ENPP1 mutations in human subjects with GACI. Manifestations are described in 5 subjects and Enpp1 mutant mice.
Methods and Materials Human Subjects
Dental and medical findings from 5 GACI patients are reported. Patients were enrolled in National Human Genome Research Institute protocol 76-HG-0238 (ClinicalTrials.gov identifier: NCT00369421) and National Institute of Dental and Craniofacial Research protocol 01-D-0184. Written informed consent was obtained from study participants or legal guardians according to guidelines of the Declaration of Helsinki.
Clinical Examination
All subjects underwent dental examination, including digital panoramic and/or periapical X-rays. Blood studies were completed as part of their medical evaluation. Exfoliated or extracted primary teeth were collected from 3 GACI subjects (10 teeth) and 4 age-matched healthy control subjects (6 teeth) for radiographic and histological analyses (Appendix Table 1 ). Additional methods for analyzing FGF23, PP i , and ENPP1 enzyme activity are reported in the Appendix.
Mice
Enpp1 mutant (Enpp1 asj/asj ) and wild-type (WT) mice (12 wk old, n = 4 to 5/genotype, including males and females; Jackson Labs C57BL/6J-Enpp1 asj /GrsrJ) were analyzed. Previous publications describe characterization of Enpp1 asj/asj mice (Li et al. 2013) . Animal studies were approved by the National Institute of Arthritis and Musculoskeletal and Skin Diseases Animal Care and Use Committee.
Micro-Computed Tomography
Micro-computed tomography (CT) was used to analyze human and mouse teeth. Samples were scanned in a µCT 50 (Scanco Medical) at 70 kVp, 76 µA, 0.5 Al filter, with 900-ms integration and 10-µm voxel dimension for human samples and 1,200-ms integration and 2-µm voxel dimension for mouse samples. Reconstructed images were analyzed using AnalyzePro 1.0 (AnalyzeDirect). Detailed methods for micro-CT analysis are described in the Appendix and Appendix Figure 1 .
Histology
Human and mouse teeth were demineralized in an acetic acid/ formalin/sodium chloride solution, paraffin embedded, sectioned at 6 µm, and stained with hematoxylin and eosin (H&E) or picrosirius red (Foster 2012) . Tartrate-resistant acid phosphatase (TRAP) staining for osteoclast/odontoclast-like cells was performed as previously described (Foster et al. 2017) . Immuno-histochemistry (IHC) was performed using a peroxidase-based kit with 3-amino-9-ethylcarbazole substrate (Vector Labs). Use of a polyclonal anti-human ENPP1 antibody (Abcam) was previously described (Zweifler et al. 2015) .
Statistical Analysis
Data were analyzed by 2-tailed Student's t test with BenjaminiHochberg false discovery rate correction for Q = 0.05 (Prism 7.02; GraphPad Software). Data are expressed as mean ± standard deviation. Additional statistical procedures are described in the Appendix.
Results

Case Descriptions
Case 1. A 6.7-y-old Caucasian female (subject 1) with a history of GACI presented with biallelic ENPP1 mutations (NM_006208.2: c.913C>A/p.P305T in exon 8; c.1499A>C/p. H500P in exon 15) (Fig. 1A) . She is the youngest of 4 children born to healthy nonconsanguineous parents, with 2 healthy older siblings and no family history of coronary artery disease (Fig. 1B) . A brother carrying the same ENPP1 mutations died at 4 mo of age due to heart failure secondary to GACI. As part of GACI management, she was treated with bisphosphonates for the first 2 y of life. She was later diagnosed with FGF23-mediated hypophosphatemic rickets (Appendix Table 2 ). Her detailed medical history is summarized in the Appendix and Appendix Figure 2A -D.
Her dental history was unremarkable for the first 2 y. Her parents noted gradual disappearance of maxillary lateral incisors (D, G) from age 2 through 6 y (Appendix Fig. 4A-C) . She was evaluated for this progressive, severe infraocclusion. Oral examination revealed a normally developing mixed dentition, apart from clinically absent maxillary primary lateral incisors and mild to moderate infraocclusion of a mandibular primary first molar (L) ( Fig.  1C, D ; Appendix Fig. 4D-H ). More than a year later (age 7.8 y), maxillary primary lateral incisors remained infraoccluded and permanent successors were unerupted (Fig.  1E) . Radiographically, there were 2 notable findings: maxillary primary lateral incisor crowns were completely infraoccluded (Fig. 1E) , and primary molars exhibited an unusually protruding morphology in the cervical root (Fig. 1F) . Maxillary primary lateral incisors and primary canines (C, D, G, H) were extracted to provide an eruption pathway for permanent incisors. Several months later, permanent incisors were erupted, although infraocclusion of mandibular primary first molar persisted (Appendix Fig. 4I-K) . No dental signs of hypophosphatemic rickets (e.g., hypoplastic or discolored enamel, thin dentin, prevalent caries, fractures, or abscesses) were noted in primary or secondary dentitions.
Case 2. A 7.11-y-old Caucasian female (subject 2) with a history of GACI and pseudoxanthoma elasticum (PXE; OMIM# 264800) presented with biallelic homozygous ENPP1 mutations (NM_006208.2: c.1538A>G; p.Y513C in exon 15) (Fig.  1G) (Li et al. 2012 ). Born to consanguineous parents, she was adopted by foster parents at 3 wk of age (Fig. 1H ). As part of GACI management, she was treated with bisphosphonates for 1.5 y between 5 and 7 y of age. Subject 2 had hypophosphatemia but no clinical or radiographic findings of Table 2 ). Her detailed medical history is summarized in the Appendix and Appendix Figure 2E -H.
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Her dental history was significant for overretained mandibular incisors, extracted at age 7 y. Oral examination revealed a normally developing mixed dentition with gingival hyperplasia ( Fig. 1I ; Appendix Fig.  5A -C) deemed to be associated with anticonvulsant and antihypertensive medications (e.g., levetiracetam and propranolol; see Appendix). While there was no evidence of caries, central incisors were mildly discolored (Fig. 1I, inset) . Dental radiographs indicated overretained maxillary incisors (D-G) ( Fig. 1J , K; Appendix Fig. 5D , E), which were extracted to provide an eruption pathway for permanent incisors. The extracted teeth exhibited a protruding root topology (Appendix Fig.  5F , G).
Case 3. A 6.11-y-old Caucasian male (subject 3) with a history of GACI and Loeys-Dietz syndrome (LDS; OMIM#60 9192) presented with biallelic ENPP1 mutations (NM_006208.2: c.1438T>C/p. C480R in exon 15; c.2414G>T/p.G805V in exon 23) (Fig. 1L) . He is the elder of 2 children born to nonconsanguineous parents, with the father presenting with LDS and a younger sister presenting with GACI (Fig. 1M) . He exhibited mild cardiovascular manifestations of GACI and was never treated with bisphosphonates. Incipient FGF23-mediated hypophosphatemic rickets was recognized at 4.2 y old (Appendix Table 2 ). His detailed medical history is summarized in the Appendix and Appendix Figure 2I , J.
His dental history was significant for crowding and suspected ankylosis of primary mandibular lateral incisors (N, Q), which were extracted at 6.3 y old to make space for permanent incisors (Appendix Fig. 6A, B) . Oral examination revealed a normally developing mixed dentition (Fig. 1N, O) . Radiographically, an unusually protruding morphology was recognized in some molar roots ( Fig. 1P; Appendix Fig. 6C, D) . No dental signs of hypophosphatemic rickets were noted in primary or secondary dentitions.
Case 4. Subject 4 is a 26.5-y-old Caucasian female with relatively mild cardiovascular manifestations of GACI who presented with biallelic ENPP1 mutations (NM_006208.2: c.749C>T/p.P250L in exon 7; c.913C>A, p.P305T in exon 8) ( Fig. 2A) . She is 1 of 3 children born to healthy nonconsanguineous parents (Fig. 2B) . A twin brother with the same ENPP1 mutations died at 6 wk of age due to myocardial infarction. Her younger sister is reportedly healthy. No bisphosphonate treatment was administered to this subject. She was diagnosed with FGF23-mediated hypophosphatemic rickets at 8 y old (Appendix Table 2 ). Her detailed medical history is summarized in the Appendix and Appendix Figure 3A -C. The subject's dental history is remarkable for an infraoccluded and ankylosed primary molar (I) at 8.9 y old (Appendix Fig. 7A ) and slow and difficult orthodontic treatment in her teenage years. Subject 4 presented a healthy dentition (Fig. 2C) , although hypercementosis on multiple teeth was indicated in radiographs from multiple ages ( Fig.  2D , E; Appendix Fig. 7B-F) . A more detailed dental history is included in the Appendix.
Case 5. Subject 5 is a 25.7-y-old Caucasian male with a history of GACI who presented with biallelic mutations in ENPP1 (NM_006208.2:c.1412A>G/p.Y471C in exon 14; c.1441C>T/ p.R481W in exon 15) (Ferreira et al. 2016) (Fig. 2F) . He is 1 of 3 children born to healthy nonconsanguineous parents ( 2G). His 30-y-old half-sister and 22-y-old brother are reportedly healthy. He was treated with bisphosphonates during his first 2 y and was diagnosed with FGF23-mediated hypophosphatemic rickets as a teenager (Appendix Table 2 ). His detailed medical history is summarized in the Appendix and Appendix Figure 3D -H. While his dental history was generally unremarkable, subject 5 presented malocclusion and crossbite (Fig. 2H) . Hypercementosis was indicated in radiographs from multiple ages ( Fig. 2I, J; Appendix Fig. 8) . A more detailed dental history is included in the Appendix.
Hypercementosis in GACI Subjects
Ten extracted teeth from GACI subjects 1 to 3 were analyzed by high-resolution micro-CT. Teeth from subjects 4 and 5 were not available for analysis. Compared to agematched controls (6 primary incisors from 4 subjects), GACI teeth exhibited dramatically increased cementum ( Fig. 3A-C;  Appendix Fig. 9 ). Segmentation and quantitative analysis of dental tissues revealed that GACI teeth featured 4-fold increased cementum thickness (adjusted P = 0.00007), while cementum mineral density was 23% higher (adjusted P = 0.009) than in control teeth (Fig. 3D, E) . Mean enamel and dentin densities were not different between GACI and control teeth (Fig. 3F, G) . Data are compiled in Appendix  Table 3 .
By histology, GACI teeth featured markedly increased cervical cementum compared to control teeth ( Fig. 4A-F) . The enlarged cementum layer in GACI teeth included cementocyte-like cells as well as empty lacunae, although this cervical region is typically acellular. While expected signs of odontoclastic/osteoclastic resorption were found in GACI primary teeth, unusual and extensive areas of reparative cementum-like material, including newly embedded cementocytes, were abundant ( Fig. 4G-I ). TRAP staining identified osteoclasts/odontoclasts on actively resorbing root surfaces, but TRAP-positive cells were absent from surfaces showing reparative cementumlike material covering resorbed edges (Appendix Fig. 10 ). Picrosirius red staining observed with polarized light microscopy demonstrated inclusion of densely packed, normally oriented Sharpey's fibers in the thick cementum of GACI teeth, confirming it as extrinsic fiber cementum (Appendix Fig. 11 ). IHC revealed selectively localized ENPP1 expression in cementoblasts lining the root surfaces of control human and mouse teeth (Fig. 4J-M) .
Hypercementosis in Enpp1 Mutant Mouse Model of GACI
Enpp1 loss-of-function mice feature decreased PP i concentrations, hypermineralization, vascular calcification consistent with that in GACI patients, and FGF23-driven hypophosphatemic rickets (Harmey et al. 2004; Mackenzie et al. 2012; Li et al. 2013) . We previously reported histological findings from Enpp1 loss-of-function mouse models (Nociti et al. 2002; Zweifler et al. 2015) and here analyzed Enpp1 asj/asj and WT mouse mandibular molars by high-resolution micro-CT in parallel to human teeth (Fig. 5) . Compared to WT, Figure 3 . Increased thickness and density of cervical cementum in teeth from generalized arterial calcification of infancy (GACI) subjects. (A) Three-dimensional micro-computed tomography (CT) reconstructions of representative incisors from 1 healthy control and 3 GACI subjects. Cementum layer is highlighted in yellow. Scale bars in panels A to C represent 2.5 mm. (B) Two-dimensional micro-CT cut plane showing hypercementosis in GACI teeth. Cementum layer is highlighted in yellow. Tooth E from GACI subject 2 features calcified pulp stone-like material (labeled in red). (C) Segmented cervical cementum layer used for thickness measurement in control and GACI teeth. Quantitative analyses of control teeth (6 teeth from 4 subjects) and 10 GACI teeth indicate (D) 4-fold significantly increased cementum thickness in GACI vs. control teeth (****adjusted P = 0.00007), (E) 23 % increase in cementum density in GACI vs. control teeth (**adjusted P = 0.009), and no differences in (F) dentin density or (G) enamel density (adjusted P > 0.05 for both). In graphs shown in panels D to G, each individual tooth measurement is displayed with color coding to indicate subject of origin, with mean ± standard deviation shown for 6 teeth from n = 4 controls and 10 teeth from n = 3 GACI subjects. For independent samples t test, multiple teeth from the same individual were first averaged to compare n = 4 control and n = 3 GACI measurements, followed by Benjamini-Hochberg false discovery rate correction for Q = 0.05.
Enpp1 asj/asj
molars exhibited 4-fold increased cervical cementum thickness (adjusted P = 0.002), 5-fold increased volume (adjusted P = 0.002), and a 5% nonsignificant increase in mineral density (Fig.  5A-G) . Apically located cellular cementum showed significantly increased volume (50%; adjusted P = 0.02) and height on mesial root surface (35%; adjusted P = 0.01) but no change in thickness or density in Enpp1 asj/asj versus WT mice (Fig. 5H-L) . No other linear, volumetric, or density measurements of dental tissues were different between Enpp1 asj/asj versus WT mice (Appendix Fig. 12 ). Histology of Enpp1 asj/ asj mouse molars resembled that of GACI subjects, including dramatically expanded cervical cementum with abnormal inclusion of embedded cells and lacunae (Appendix Fig. 13 ).
Discussion
We report for the first time dental manifestations of inactivating ENPP1 mutations in 5 individuals with GACI, all presenting significant hypercementosis of cervical cementum in primary and/or secondary dentition. Similar to GACI subjects, Enpp1 asj/asj mice exhibited significant hypercementosis. Dental histories of 4 GACI subjects included evidence for infraocclusion, overretained primary teeth, possible ankylosis, and/or ineffective orthodontic tooth movement, suggesting altered mineral metabolism contributing to disrupted tooth movement and exfoliation. While 4 of 5 GACI subjects presented with signs of hypophosphatemic rickets, associated deleterious effects on dental tissues were not evident. Immunolocalization of ENPP1 in human and mouse cementoblasts supports a specific role for this protein in controlling cementogenesis. Collectively, these findings illustrate a novel dental phenotype in GACI and ENPP1 mutations associated with hypercementosis. The sensitivity of cementum to reduced PP i levels in both human and mouse teeth establishes this mechanism as a well-conserved and fundamental biological process directing cementogenesis across species.
Influence of Pyrophosphate on Cementogenesis
ENPP1 is a membrane-bound enzyme of the ectonucleotide pyrophosphatase/phosphodiesterase family (Stefan et al. 2005) expressed by osteoblasts and chondrocytes, which contributes to regulation of skeletal mineralization (Millán 2013) . ENPP1 generates intracellular/extracellular PP i by hydrolyzing ATP to AMP and PP i . ENPP1-derived PP i is critical for preventing pathological soft tissue calcification, and decreased PP i levels account for GACI-associated pathologic calcifications (Rutsch et al. 2003; Ferreira et al. 2014) . We reported previously that extracellular PP i deficiency in Enpp1 mutant and knockout mice contributes to increased acellular cementum formation (Nociti et al. 2002; . A nearly identical cementum phenotype is noted in mice with loss of function of ANK, a transmembrane protein that mediates transport of intracellular PP i to the extracellular space (Nociti et al. 2002; . However, to date, it remained unclear if the role of ENPP1 in tooth development is conserved between Figure 4 . Histological analysis of hypercementosis in teeth from generalized arterial calcification of infancy (GACI) subjects. Histology sections of (A, B) healthy control incisor compared to (C, D) incisor and (E, F) canine from GACI subject 1 reveal dramatically increased acellular cementum (AC) in GACI teeth. Both GACI teeth exhibit embedded nucleated cementocytelike cells and empty lacunae (D and F) unusual for cervical cementum. (G-I) GACI teeth exhibit patterns of adjacent resorption and reparative cellular cementum (black arrows), unusual for primary teeth undergoing exfoliation. Immunohistochemistry for ENPP1 protein in control (J, K) human and (L, M) mouse molar sections reveals selective elevated ENPP1 in cementoblasts (Cb) lining AC surfaces, with fewer positive Cb on the cellular cementum (CC) surfaces. AB, alveolar bone; DE, dentin; PDL, periodontal ligament. mouse and human, as key differences between the 2 include extremely rapid tooth formation in mice (weeks rather than years) and formation of only a single dentition in mice. It has also been unclear whether different proteins exert more dominant influences on cementogenesis in different species. Our results indicate that hypercementosis of cervical cementum from ENPP1 loss of function is consistent in humans and mice. Bisphosphonates affect bone remodeling and have been linked to altered/ectopic bone deposition and so might be suspected in hypercementosis. However, it is important to note that cementum does not undergo physiological remodeling, and bisphosphonate administration to rodents inhibits acellular cementum formation (Beertsen et al. 1985) . Furthermore, GACI subjects 3 and 4 and Enpp1 asj/asj mice all featured hypercementosis without bisphosphonate treatment.
ENPP1 immunolocalization in cementoblasts of both mouse and human teeth supports its role as a regulator of cementum growth under physiological circumstances through local production of PP i . However, while previous studies support a local role for ENPP1 and PP i in directing mineralization (Anderson et al. 2005; , we cannot rule out the influence of systemic factors based on these data. In contrast to ENPP1, TNAP reduces PP i and loss-of-function mutations in ALPL cause HPP, a disorder where elevated PP i causes skeletal hypomineralization (Whyte 2016 ) and acellular cementum aplasia or hypoplasia (Foster, Ramnitz, et al. 2014b) , the exact opposite effect of hypercementosis noted in GACI subjects with pathologically low PP i .
Additional Dental Manifestations of GACI
Individuals with GACI who survive infancy may develop autosomal recessive hypophosphatemic rickets type 2 (ARHR2; OMIM#613312) within the first decade of life. ARHR2 is characterized by elevated FGF23, decreased serum phosphate, decreased renal phosphate reabsorption, and elevated serum alkaline phosphatase (Rutsch et al. 2008; Levy-Litan et al. 2010; Lorenz-Depiereux et al. 2010; Ferreira et al. 2016) . The etiology of ARHR2 is unclear. Onset of ARHR2 can be as early as 1 y old, and primary and secondary teeth during this stage are sensitive to mineral disturbances as evidenced by other forms of nutritional and inherited rickets, for example, X-linked hypophosphatemia (XLH; OMIM#307800) and vitamin D-dependent rickets (VDDR1A; OMIM#264700) (Davit-Beal et al. 2014; Biosse Duplan et al. 2016 ). These metabolic disturbances cause severe enamel and dentin defects, making teeth susceptible to caries, fractures, and abscesses. Four GACI subjects described in this study showed skeletal and biochemical signs of ARHR2 (Appendix Table 2 ; Appendix Fig. 2 ). However, subjects 1 to 4 showed no signs of rachitic dental manifestations. Subject 5 presented unusual cusp patterns and a history of extensive sealant application, as noted previously (Ferreira et al. 2016) . While these observations are consistent with very mild enamel effects, in isolation they are not strong evidence of rachitic teeth. Administration of bisphosphonates in infancy could also plausibly disturb dental mineralization based on prior reports in humans and rodents (BradaschiaCorrea et al. 2007; Hiraga et al. 2010; Iwai et al. 2013; Soares et al. 2016) .
Primary molars were infraoccluded in subjects 1 and 4, in addition to atypical infraocclusion of primary incisors in subject 1. Subject 2 presented failure of natural exfoliation of primary incisors. Etiology of infraocclusion is difficult to determine, with hypotheses including ankylosis, impaction, absence of successor, damage to developing root, bone defects, and metabolic disturbances (Noble et al. 2007 ). Mandibular first primary molars are reportedly the most commonly affected teeth (McGeown and O'Connell 2014) with no existing reports of infraoccluded anterior teeth. Ankylosis might be suspected due to altered periodontal mineralization but was not identified in retained teeth in subjects 1 and 2, although it was indicated in mandibular primary incisors in subject 3 and the infraoccluded primary molar in subject 4. Substantial root structure remained on teeth from subjects 1 (extracted at 8 y old) and 3 (extracted at 6 y old) compared to healthy controls, and there was histological evidence of extensive repair cementum in teeth from subject 1, suggesting that new cementum formation could have been opposing and reversing odontoclast activities. Altered resorption may also be suspected. While defective osteoclast/ odontoclast resorption has not been linked to ENPP1 in humans or animal models (Hajjawi et al. 2014) , loss of function of ANK/ANKH contributes to osteoclast dysfunction in craniometaphyseal dysplasia (Chen et al. 2014) . Intriguingly, orthodontic records for subject 4 report difficulty in orthodontic tooth movement, suggesting reduced bone resorption. Another hypothesis for infraocclusion arises from bisphosphonate treatment, a lifesaving intervention that may have unintended consequences on skeletal and dental tissues (Rutsch et al. 2008; Edouard et al. 2011; Otero et al. 2013; Soares et al. 2016) . Bisphosphonate administration in animals disrupted tooth eruption (Grier and Wise 1998; Bradaschia-Correa et al. 2007; Hiraga et al. 2010) and was associated with delayed eruption in humans (KamounGoldrat et al. 2008; Iwai et al. 2013) . However, subject 4, who experienced both infraocclusion and slow orthodontic tooth movement, was never treated with bisphosphonates, suggesting that ENPP1 mutations are responsible. Strikingly, a previous report of familial hypercementosis noted infraocclusion of several molars and premolars, recalcitrance to orthodontic tooth movement, and abnormal deposition of cementum layers over resorption lacunae (Humerfelt and Reitan 1966) . These and other findings in human subjects warrant further studies to elucidate underlying mechanisms.
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